Zydus Receives Final Approval from USFDA for Leuprolide Acetate Injection
Zydus has secured final USFDA approval for its Leuprolide Acetate injection, a multiple-dose formulation indicated for the palliative treatment of advanced prostate cancer.
Advanced Prostate Cancer | 15/11/2025 | By Dineshwori
Foresee Pharmaceuticals has received US FDA approval for CAMCEVI ETM (21 mg) as a treatment for advanced prostate cancer.
Advanced Prostate Cancer | 30/08/2025 | By Mrinmoy Dey | 274
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy